In the year 2020, the world has changed and it will never be the same. Global economy was severely contracted due to the COVID-19 Pandemic. According to World Bank forecasts, the global economy will shrink by 5.2% this year which is the deepest recession since the Second World War (the World Bank, June 2020 Global Economic Prospects). Nonetheless, in the mid of this epidemic crisis, there are hopes and opportunities in healthcare industry. Since last year, we have known that life science industry in Thailand has grown steadily 5 - 6% in overall and it could grow rapidly after the COVID-19 due to a huge demand of clinical research studies, medical supplies, medical services, and digital health. Thailand has shown the capability to handle the COVID-19 epidemic crisis with excellence. Therefore, this opportunity must be capitalized by the investors and top selected life science companies. TCELS realized the importance of this opportunity, we have been driving Pharmaceutical/ Medical Biotechnology Industry, Medical Devices/ Biomedical Robotic Industry, Natural Extract/ Cosmeceutical/ and Nutraceutical Industry, Clinical Research Office (CRO) and Standardization Services for the sustainable development of Life Sciences Industries in Thailand.
